Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood;Die inhibitoren von tumor nekrose faktor alpha zur behandlung von arthritis und uveitis im kindesalter

Klinische Monatsblatter fur Augenheilkunde

Volumn 224, Issue 6, 2007, Pages 526-531

  Heiligenhaus, Arnd ^a,b   Horneff, C ^c   Greiner, K ^d   Mackensen, F ^e   Zierhut, M ^f   Foeldvari, I ^g   Michels, H ^h  

^a ST FRANZISKUS HOSPITAL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Asklepios Klinik für Kinder und Jugendmedizin Sankt Augustin   (Germany)

^d CARL THIEM KLINIKUM   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g Hamburger Zentrum fur Kinder und Jugendrheumatologie   (Germany)

^h German Center for Pediatric and Adolescent Rheumatology   (Germany)

Author keywords

Adalimumab; Corticosteroids; Etanercept; Immunsuppression; Infliximab; Iridocyclitis; Juvenile idiopathic arthritis; TNF inhibitors; Uveitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISOLONE ACETATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTHRITIS; CHILDHOOD DISEASE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOMA; RECURRENT DISEASE; REVIEW; TUBERCULOSIS; UVEITIS; VISUAL IMPAIRMENT;

EID: 34547116872     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963174     Document Type: Review

References (29)

1. Biester S, Michels H, Haefner R et al. Etanercept in the treatment of chronic anterior uveitis in children. Invest Ophthalmol Vis Sci Abstract ARVO 2004; 45: 2668
2. Bongartz T, Sutton AJ, Sweeting MJ et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systemic review and meta-analysis of rare harmful effects in randomized controlled studies. JAMA 2006; 295: 2275-2285
3. Braun J, Baraliakos X, Listing J et al. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the antitumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 2005; 52: 2447-2451
4. Breedveld FC, Weisman MH, Kavanaugh AF et al. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006; 54: 26-37
5. Chakravarty EF, Michaud K, Wolfe F. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol 2005; 32: 2130-2150
6. Doycheva D, Deuter C, Stuebiger N et al. Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol 2006; Epub ahead of print
7. Foeldvari I, Kümmerl-Deschner J, Nielson S et al. Tumor necrosis factor alpha blocker are effective in the treatment of juvenile idiopathic arthritis associated uveitis refractory to second line agents: results of the multinational survey. 2005 Annual Scientific Meeting of the American College or Rheumatology, San Diego, Ca., USA. Arthritis Rheum 2005; 52 (Suppl 1): A 1416
8. Honkanen V, Lappi M, Koskinen L et al. Infliximab treatment in the refractory chronic uveitis of juvenile idiopathic arthritis (JIA). Arthritis Rheum 2001; 44 (Suppl 1): 292
9. Horneff G, Burgos-Vargas R. TNF-alpha antagonists for the treatment of juvenile-onset spondylarthritides. Clin Exp Rheumatol 2002; 20: 137-142
10. Horneff G, Schmeling H, Biedermann T et al. The German Etanercept Registry for Treatment of Juvenile Idiopathic Arthritis. Ann Rheum Dis 2004; 63: 1638-1644
11. Kahn P, Weiss M, Imundo LF et al. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 2006; 113: 860-846
12. Kaipiainen-Seppänen O, Leino M. Recurrent uveitis in a patient with juvenile spondylarthropathy associated with tumour necrosis factor inhibitors. Ann Rheum Dis 2003; 62: 88-89
13. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345: 1098-1104
14. Kotaniemi K, Tynjälä P, Honkanen V. New biological agents in the treatment of juvenile idiopathic arthritis associated uveitis. 103. DOG Congress 2005
15. Lovell DJ, Reiff A, Jones OY et al. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2006; 54: 1987-1994
16. Lovell DJ, Ruperto N, Cuttica R et al. Comparison of safety, efficacy and pharmacokinetics for 3 and 6 mg/kg infliximab plus methotrexate therapy in JRA patients. Arthritis Rheum 2005; 52: 724
17. Mangge H, Heinzl B, Grubbauer HM et al. Therapeutic experience with infliximab in a patient with polyarthritis juvenile idiopathic arthritis and uveitis. Rheumatol Int 2003; 23: 258-261
18. Mohan N, Edwards ET, Cupps TR et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001; 44: 2862-2869
19. Rajaraman RT, Kimura Y, Li S et al. Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology 2006; 113: 308-314
20. Reddy AR, Backhouse OC. Does etanercept induce uveitis? Br J Ophthalmol 2005; 89: 925
21. Reiff A, Takei S, Sadeghi S et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 2001; 44: 1411-1415
22. Richards JC, Tay-Kearney ML, Murray K et al. Infliximab for juvenile idiopathic arthritis-associated uveitis. Clin Exp Ophthalmol 2005; 33: 461-468
23. Saurenmann RK, Levin AV, Rose JB et al. Tumour necrosis factor inhibitors in the treatment of childhood uveitis. Rheumatology 2006; Epub ahead of print
24. Schmeling H, Horneff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology 2005; 44: 1008-1011
25. Smith JR, Levinson RD, Holland GN et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001; 45: 252-257
26. Smith JA, Thompson DJ, Whitcup SM et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 2005; 53: 18-23
27. Tappeiner C, Heinz C, Zurek-Imhoff B et al. Treatment of juvenile uveitis with TNF-α inhibitors. 104. DOG Congress 2006
28. Vazquez-Cobian LB, Flynn T, Agle LMA et al. Treatment of resistant uveitis in children with adalimumab. Abstract SY24, Poster 475 ACR Meeting 2003
29. Wallis Wj, Burge Dj, Holman J et al.. Infection reports with etanercept (Enbrel) therapy. Arthritis Rheum 2001; 44: 78